You are here

  • Home
  • Archive
  • Volume 57, Issue 7
  • Republished: Metformin-associated lactic acidosis precipitated by liraglutide use: adverse effects of aggressive antihyperglycaemic therapy

Article Text

Article menu
Download PDFPDF
Republished “[case report]”
Unexpected outcome (positive or negative) including adverse drug reactions
Republished: Metformin-associated lactic acidosis precipitated by liraglutide use: adverse effects of aggressive antihyperglycaemic therapy
  1. Ananya Hooda1,
  2. Anurag Mehta2,
  3. Franck Hannallah3
  1. 1 Hematology and Oncology, Emory University School ofMedicine, Atlanta, Georgia, USA
  2. 2 Cardiology, Emory UniversitySchool of Medicine, Atlanta, Georgia, USA
  3. 3 Department of InternalMedicine, Pulmonary andCritical Care, University of TexasSouthwestern, Dallas, Texas, USA
  1. Correspondence to Franck Hannallah; franckhannallah{at}gmail.com

Abstract

In conjunction with BMJ Case Reports, DTB will feature occasional drug-related cases that are likely to be of interest to readers. These will include cases that involve recently marketed drugs for which there is limited knowledge of adverse effects and cases that highlight unusual reactions to drugs that have been marketed for several years.

  • diabetes
  • drugs: endocrine system
  • unwanted effects / adverse reactions

https://doi.org/10.1136/dtb.2019.227102rep

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Republished from Hooda A, Mehta A, Hannallah F. Metformin-associated lactic acidosis precipitated by liraglutide use: adverse effects of aggressive antihyperglycaemic therapy. BMJ Case Rep 2018. doi: 10.1136/bcr-2018-227102

    • Contributors All authors made substantial contributions to conception and design of the work; gave final approval of the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. AM and FH performed the acquisition, analysis and interpretation of data for the work and revised it critically for important intellectual content. AH drafted the work.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Patient consent for publication Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.